Cargando…
Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy
Melanoma is responsible for most skin cancer-related deaths and is one of the most common cancers diagnosed in young adults. In melanoma, tumors can become established by activation of the negative regulator of cytotoxic T lymphocytes (CTLs), CTL antigen-4 (CTLA-4). Ipilimumab blocks the interaction...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485758/ https://www.ncbi.nlm.nih.gov/pubmed/26155423 http://dx.doi.org/10.1080/2162402X.2015.1008842 |